Anne Hyland

Anne Hyland

Corporate Officer/Principal at
London Stock Exchange Plc
66 year
Health Technology
Consumer Services
Commercial Services

Profile

Anne Philomena Hyland is currently a Member-Primary Markets Group at London Stock Exchange Plc.
She previously worked as a Finance Director at Celltech Group Plc and Medeva Plc.
From 2010 to 2013, she was the CFO, Secretary & Executive Director at Vectura Group Ltd. She also served as an Independent Non-Executive Director at Elementis Plc from 2013 to 2022 and at Clinigen Ltd. from 2018 to 2022.
She was the Chief Financial Officer & Director at BBI Diagnostics Group 2 Plc and the Chief Financial Officer & Secretary at BBI Diagnostics Group Ltd. She worked as an Audit Manager at KPMG Audit Plc.
From 2015 to 2021, she was the Chief Financial Officer & Secretary at Kymab Ltd. She was a Trustee at Sustrans Ltd. from 2012 to 2017.
Ms. Hyland received an undergraduate degree from Trinity College Dublin.

Anne Hyland active positions

CompaniesPositionStart
Corporate Officer/Principal -

Former positions of Anne Hyland

CompaniesPositionEnd
MEREO BIOPHARMA GROUP PLC Director/Board Member 2022-11-09
ELEMENTIS PLC Director/Board Member 2022-04-25
CLINIGEN GROUP PLC Director/Board Member 2022-03-31
Director of Finance/CFO 2021-03-31
Director/Board Member 2016-12-31
See the detail of Anne Hyland's experience

Training of Anne Hyland

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

60

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Process Industries

Health Technology

Consumer Services

Commercial Services

Finance

Health Technology

Consumer Services

Commercial Services

Health Services

Health Technology